A quick clotting test could make transfusions safer for children in surgery
NCT ID NCT05379530
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This study looks at whether a rapid blood test called thromboelastography (TEG) can help doctors manage bleeding during high-risk surgeries in children. TEG measures how well blood clots in real time, which might guide decisions about which blood products to give. The study will observe children undergoing surgeries with a high chance of needing a transfusion, such as spinal or major abdominal surgery, and compare transfusion practices to historical data. The goal is to see if TEG helps doctors use the right type and amount of blood products, potentially improving safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Thromboelastography (TEG), a point-of-care blood test that assesses clotting function during surgery
- What this could lead to
- If TEG proves useful, it could help doctors give the right blood products to children during major surgery, reducing complications from too few or too many transfusions.
- What could go wrong
- This is a small, single-center observational study, so results may not apply broadly. TEG is not yet standard for pediatric non-cardiac surgery, and its impact on outcomes remains uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST OPERATIVE HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.